Zhejiang Wolwo Bio-Pharmaceutical Co Ltd banner
Z

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357

Watchlist Manager
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
Watchlist
Price: 24.99 CNY 1.09% Market Closed
Market Cap: ¥13.1B

Wall Street
Price Targets

Price Targets Summary
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is 31.54 CNY with a low forecast of 23.82 CNY and a high forecast of 40.17 CNY.

Lowest
Price Target
23.82 CNY
5% Downside
Average
Price Target
31.54 CNY
26% Upside
Highest
Price Target
40.17 CNY
61% Upside
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors:
Price Targets
JEF
Jefferies Financial Group Inc
119% Upside

Revenue
Forecast

18% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
18% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's revenue is 18%. The projected CAGR for the next 3 years is 19%.

Operating Income
Forecast

17% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
17% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 13 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 25%.

Net Income
Forecast

18% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
18% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 13 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's net income is 18%. The projected CAGR for the next 3 years is 23%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's stock price target?
Price Target
31.54 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is 31.54 CNY with a low forecast of 23.82 CNY and a high forecast of 40.17 CNY.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
19%

For the last 13 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's revenue is 18%. The projected CAGR for the next 3 years is 19%.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
25%

For the last 13 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 25%.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
23%

For the last 13 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's net income is 18%. The projected CAGR for the next 3 years is 23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett